These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10262235)

  • 1. Grantees' overhead costs: should foundations pay?
    Foote J
    Found News; 1983; 24(3):51-5. PubMed ID: 10262235
    [No Abstract]   [Full Text] [Related]  

  • 2. Philanthropy's new agenda: creating value.
    Porter ME; Kramer MR
    Harv Bus Rev; 1999; 77(6):121-30, 216. PubMed ID: 10662001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Private philanthropy and public service policy: a New York City case.
    Shires GT
    Grants Mag; 1979 Sep; 2(3):178-86. PubMed ID: 10244937
    [No Abstract]   [Full Text] [Related]  

  • 4. Addiction's handsome nonprofit. Can others match Phoenix House's fundraising, programmatic gains?
    Ringwald CD
    Behav Healthc Tomorrow; 2000 Oct; 9(5):10-5, 37. PubMed ID: 11143094
    [No Abstract]   [Full Text] [Related]  

  • 5. New York City group leads the way toward a more optimistic future for ASOs. ASO went from near bankruptcy to $26 million.
    AIDS Alert; 2004 Jul; 19(7):73, 75-6. PubMed ID: 15241858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome Canada. New awards bolster Canada's global role.
    Kondro W
    Science; 2002 Apr; 296(5566):239-41. PubMed ID: 11951012
    [No Abstract]   [Full Text] [Related]  

  • 7. Health plan foundations. How well are they spending the money?
    Glabman M
    Manag Care; 2008 Aug; 17(8):16-7, 21-4, 26. PubMed ID: 18777785
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer group denies company funding will influence its agenda.
    Watson R
    BMJ; 2006 Oct; 333(7574):874. PubMed ID: 17068021
    [No Abstract]   [Full Text] [Related]  

  • 9. U.S. science policy. Going from RAGS to riches is proving to be very difficult.
    Mervis J
    Science; 2008 May; 320(5877):728-9. PubMed ID: 18467560
    [No Abstract]   [Full Text] [Related]  

  • 10. Forecasters of a more cost-effective future: Part Two. Interview by Joyce Glidea.
    Sharpe RS
    Health Cost Manage; 1987; 4(1):10-7. PubMed ID: 10281298
    [No Abstract]   [Full Text] [Related]  

  • 11. The ABCs of grant writing or "always be certain".
    Murphy NR
    Fund Raising Manage; 1999 Aug; 30(6):30-1. PubMed ID: 10558161
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonprofit foundations for open-source biomedical technology development.
    Frangioni JV
    Nat Biotechnol; 2012 Oct; 30(10):928-32. PubMed ID: 23051807
    [No Abstract]   [Full Text] [Related]  

  • 13. Tax-exempt targets. IRS introduces initiative to examine executive compensation, excess benefits.
    Taylor M
    Mod Healthc; 2004 Aug; 34(33):10-1. PubMed ID: 15356982
    [No Abstract]   [Full Text] [Related]  

  • 14. A team approach to volunteer recruitment in New York City.
    Wyant S
    Volunt Leader; 1993; 34(2):4-6. PubMed ID: 10126507
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating the Health Research Council.
    Piel G
    Bull N Y Acad Med; 1971 Jul; 47(7):814-9. PubMed ID: 5283135
    [No Abstract]   [Full Text] [Related]  

  • 16. Resource guide to professional cancer organizations, programs, and foundations.
    Cericola SA
    Plast Surg Nurs; 1999; 19(3):161-4. PubMed ID: 10765302
    [No Abstract]   [Full Text] [Related]  

  • 17. NIDCR grantees' participation in the ADEA commission on change and innovation.
    Rossomando EF; Moura M
    J Dent Educ; 2006 Dec; 70(12):1259; author reply 1259-60. PubMed ID: 17170313
    [No Abstract]   [Full Text] [Related]  

  • 18. New non-profit organization will support research to combat neglected diseases.
    Walgate R
    Bull World Health Organ; 2002; 80(10):842-3. PubMed ID: 12471410
    [No Abstract]   [Full Text] [Related]  

  • 19. Industry-sponsored economic studies in critical and intensive care versus studies sponsored by nonprofit organizations.
    Hartmann M; Knoth H; Schulz D; Knoth S; Meier-Hellmann A
    J Intensive Care Med; 2003; 18(5):265-8. PubMed ID: 15035761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalization--megatrend for the progressive agency.
    Conroy CP
    Fund Raising Manage; 1984 Aug; 15(6):16-21. PubMed ID: 10317480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.